Metraipolis › archive › dc_8224f441b026

Reversal of T cell exhaustion enables cancer vaccine efficacy in BRCA1-deficient ovarian cancer — Europe PMC PMID:42491848

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42491848
DOI
10.1016/j.isci.2026.116587
License (as archived)
solo-consultazione
Archived
2026-10-31T06:29:41.554Z
SHA-256 of the archived text
686209e117a148308b7c38516ee815ff8e9178176d58f2dc8e5a04afff152913
Stable URL of this page
https://metraipolis.com/documento/dc_8224f441b026

How to cite

Reversal of T cell exhaustion enables cancer vaccine efficacy in BRCA1-deficient ovarian cancer — Europe PMC PMID:42491848 — Europe PMC (en), https://europepmc.org/article/MED/42491848 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_8224f441b026 (Metraipolis archive dc_8224f441b026, sha256 686209e117a148308b7c38516ee815ff8e9178176d58f2dc8e5a04afff152913)
BibTeX
@misc{dc8224f441b026,
  title = {Reversal of T cell exhaustion enables cancer vaccine efficacy in BRCA1-deficient ovarian cancer — Europe PMC PMID:42491848},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42491848},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_8224f441b026; sha256 686209e117a148308b7c38516ee815ff8e9178176d58f2dc8e5a04afff152913},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42491848. Agents can read the archived copy with the MCP tool read_document.